Trial Profile
Influenza vaccination with PREFLUCEL: vaccination motivation and tolarability
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Baxter Corporation
- 06 Jul 2012 Planned end date 21 Nov 2011 added as reported by German Clinical Trials Register record.
- 23 Nov 2011 Status changed from not yet recruiting to discontinued as reported by German Clinical Trials Register record.
- 23 Nov 2011 Actual initiation date 12 Sep 2011 added as reported by German Clinical Trials Register record.